Anti-hyperlipidemic effect of flavone-rich Belamcanda chinensis (L.) DC. (Iridaceae) leaf extract in ICR mice fed high-fat diet
Purpose: To assess the anti-hyperlidemic effect of flavone-rich B. chinensis leaf extract (HTP) in ICR mice fed a high-fat diet.
Methods: HTP (100, 200 and 400 mg/kg) were orally administered to ICR mice fed high-fat diet for 7 weeks. Blood glucose, as well as serum and hepatic levels of lipids were determined at the end of the experiment. Phosphorylation of adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) and protein level of peroxisome proliferator-activated receptor α (PPARα) were analyzed by Western blot and enzyme-linked immunosorbent assay (ELISA) kit, respectively.
Results: Treatment with HTP significantly decreased peri-epididymal fat weight (p < 0.01 and p < 0.05 for 200 and 100 mg/kg, respectively), lowered serum and hepatic lipid, and decreased glucose area under curve (AUC) in oral glucose tolerance test (p < 0.01 for 200 mg/kg). Western blot and ELISA analysis showed that administration of HTP (200 mg/kg) significantly increased AMPK (p < 0.05) phosphorylation and PPARα expression in liver (p < 0.05).
Conclusion: HTP can alleviate hyperlipidemia, at least in part, by up-regulation of AMPK and PPARα.
Keywords: Belamcanda chinensis, Flavone, Hyperlipidemia, Adenosine 5′-monophosphate-activated protein kinase, Peroxisome proliferator activated receptor-alpha, Glucose tolerance
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.